Ubiquitination modifications as central regulators of metabolic dysfunction in type 2 diabetes mellitus - Takeaways - MDSpire

Ubiquitination modifications as central regulators of metabolic dysfunction in type 2 diabetes mellitus

  • By

  • Wen-tao Wang

  • Ze-ya Shi

  • Hai-long Wang

  • Zhao-yang Chen

  • July 9, 2026

  • 0 min

Share

  • 1

    Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, pancreatic β-cell dysfunction, and multi-organ metabolic dysregulation.

  • 2

    Ubiquitination is a central regulator of cellular homeostasis, influencing the stability and activity of key signaling proteins.

  • 3

    E3 ubiquitin ligases and deubiquitinating enzymes (DUBs) form tissue-specific regulatory networks that govern T2DM pathology.

  • 4

    The review highlights the need for enzyme-specific resolution and a multi-organ integration approach in understanding T2DM.

  • 5

    Emerging strategies such as single-cell omics and AI-assisted drug discovery are discussed for potential therapeutic interventions in T2DM.

Original Source(s)

Ubiquitination modifications as central regulators of metabolic dysfunction in type 2 diabetes mellitus

  • by Wen-tao Wang, Ze-ya Shi, Hai-long Wang, Zhao-yang Chen

  • July 9, 2026

Related Content

Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and Bayesian network meta-analysis

Thyroid feedback quantile-based index predicts 90-day all-cause mortality or readmission in hospitalized heart failure patients: a retrospective cohort study

Therapeutic monoclonal antibodies for diabetic kidney disease: a narrative review from basic mechanisms to clinical evidence